PVPEvervie Health Ltd.

    Evervie Health Q2 FY27 Results: Standalone Net Profit ₹1.86 Crore on Total Income of ₹14.25 Crore

    • Earnings
    • healthcare and diagnostics
    Blood sample collection tubes with coloured caps arranged in a metal tray beside a yellow sharps disposal container
    Fumikas Sagisavas, via Wikimedia Commons (CC0). Illustrative image.

    Evervie Health Ltd reported standalone total income of ₹14.25 crore and a net profit of ₹1.86 crore for the quarter ended 30 Sep 2026, against a net loss of ₹3.97 crore a year earlier. The Board approved the results at its meeting on 13 Nov 2026.

    Key highlights

    Standalone

    The company on its own, without its subsidiaries

    • Total income: ₹14.25 crore, up 64.4% YoY and down 63.4% QoQ
    • Net profit and EPS: ₹1.86 crore; basic EPS ₹0.07, against a loss of ₹0.15 a year earlier
    • Finance costs: ₹9.31 crore, up 14.2% YoY and 65.3% of total income
    • Other income: ₹3.12 crore, down from ₹25.43 crore in the June quarter

    Summary

    Standalone ₹ crore
    ParticularsQ2 FY27Q2 FY26YoYQ1 FY27QoQ
    14.258.67+64.4%38.92-63.4%
    1.86-3.97n/a15.11-87.7%
    EPS, basic (₹)0.07-0.15n/a0.58-87.9%

    Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.

    Net profit is positive for the quarter, but it rests on a narrow operating base. Revenue from operations of ₹11.13 crore is up 119.5% on the year-earlier ₹5.07 crore, yet finance costs of ₹9.31 crore equal 83.6% of it. Profit before tax is ₹1.05 crore, and a tax credit of ₹0.80 crore takes net profit to ₹1.86 crore.

    Other income is the other side of the picture. It was ₹3.12 crore, 21.9% of total income, down 13.3% on a year earlier and 87.7% on the June quarter's ₹25.43 crore. Of the ₹3.12 crore, ₹3.03 crore is interest on the 22% secured redeemable non-convertible debentures of New Cyberabad City Projects Private Limited, which the company recognises as other income; that is 97.1% of the line. Half-year interest on these debentures of ₹5.51 crore implies ₹2.48 crore in the June quarter.

    The June quarter carried an exceptional impairment loss of ₹10.85 crore on the investment in Humain Healthtech Private Limited. The company says its estimated recoverable amount was lower than the carrying amount of that investment. No exceptional item is shown for the September quarter, so the two quarters are not comparable on profit before tax.

    Inference

    The auditors CNGSN and Associates LLP issued a limited review report on the standalone results, stating that nothing has come to their attention that causes them to believe the statement is not prepared in accordance with Ind AS 34. The company changed its name from PVP Ventures Limited to Evervie Health Limited with effect from 5 Oct 2026. It holds 41.23% of 7Med India Private Limited after acquiring a further 7.99% stake for ₹19.26 crore, with an effective date of 1 Apr 2026.

    The filing does not say why other income fell from ₹25.43 crore to ₹3.12 crore, or whether the debentures carried at ₹140.89 crore will be repaid and when. Segment information is given only in the consolidated results, so the standalone figures are not split by segment.

    Filed with BSE on . Reference: Original filing (PDF)

    Disclaimer:

    The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.

    Related posts

    All Evervie Health Ltd. articles